Biomed. Pharmacother.
MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X, Dong J, He X, Shen L, Long C, Liu F, Liu X, Lin T, He D, Wei G
MicroRNA-155-5p (miR-155-5p) has been reported to play an oncogenic role in different human malignancies; however, its role in Wilms tumor (WT) remain ...
Read More
Source: PubMed
CASE (Phila)
Atrial Thrombus Mimicking Ewing's Sarcoma.
Hon M, Danda N, Currie E, Weerasooriya S
Read More
Source: PubMed
J Orthop Surg Res
Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study.
Xie L, Huang W, Wang H, Zheng C, Jiang J
Large population-based studies of risk factor for lung metastases at the presentation with primary osseous neoplasms are lacking and necessary. We aim ...
Read More
Source: PubMed
Cancer Cytopathol 2020 Jan 29
EWSR1 fusions: Ewing sarcoma and beyond.
Jo VY
Read More
Source: PubMed
Mol Cell Oncol
Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer.
Musa J, Grünewald TGP
Deciphering principles of inter-tumoral heterogeneity is crucial for refinement of precision oncology. We have recently demonstrated that 'oncogenic c ...
Read More
Source: PubMed
